Back to Pharma & Biotech Public Relations


Coyne PR partnered with Gilead’s Oncology Community Engagement and Advocacy team to develop a multi-tier advocacy strategy to deliver on Gilead’s commitment to championing equitable cancer care for all. Coyne collaborated with Gilead Oncology to create its first global Oncology Advocacy Steering Committee Summit and convened Gilead’s first Health Equity Advisory Board, featuring national advocacy leaders in triple-negative breast cancer (TNBC) who sought to reimagine health equity in cancer care and ideate on solutions to address current disparities in TNBC.

Coyne also helped organize Gilead’s inaugural Health Equity Incubation Lab to discuss how to address health disparities for those living with TNBC. The event engaged patient leaders and online influencers in dynamic discussions that have helped Gilead understand, anticipate and address unmet needs within the TNBC community.  While Coyne’s charge did not involve media relations, the events still had a